Qualité des gamètes dans le cadre de l’utilisation post-cancer (notice n° 1729079)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03310cam a2200373 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260322003103.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Giscard d’Estaing, Sandrine |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Qualité des gamètes dans le cadre de l’utilisation post-cancer |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2024.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 90 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The quality of cryopreserved gametes before gonadotoxic treatment or available after cancer depends on several parameters before, during and after cryopreservation. In men, sperm quality may be impaired by clinical conditions at the time of sperm cryopreservation. Their quality can also be altered by treatments and freezing technique. Fertility restoration varies depending on depending on received treatment and individual. In the case of hematopoietic stem cell transplantation, even in the case of azoospermia, testicular extraction by TESE may be positive. In women, the ovarian reserve cannot be restored after cancer, which makes fertility preservation particularly important. Pregnancy rates depend on the quality of the oocytes, which is directly related to the number of cryopreserved oocytes and the age of the patient. Finally, the implementation of secondary feminine fertility preservation in patients who have had cancer in childhood or adolescence appears necessary to limit the risk of fertility impairment. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | La qualité des gamètes cryoconservés avant un traitement potentiellement stérilisant ou disponibles après un cancer dépend de plusieurs paramètres avant, pendant et après cryoconservation. Chez l’homme, la qualité des spermatozoïdes peut être altérée par les conditions cliniques au moment de la cryoconservation des spermatozoïdes. Leur qualité peut également être altérée par les traitements et la technique de congélation. La restauration de la fertilité est variable selon les traitements reçus et est individu-dépendante. En cas de greffe de cellules souches hématopoïétiques, même en cas d’azoospermie, l’extraction testiculaire (testicular sperm extraction) peut se révéler positive. Chez la femme, la réserve ovarienne ne peut pas être restaurée après un cancer, ce qui rend la préservation de la fertilité particulièrement importante. Les taux de grossesse dépendent de la qualité des ovocytes directement liée au nombre d’ovocytes cryoconservés et à l’âge de la patiente. Enfin la mise en place d’une préservation secondaire de la fertilité féminine chez les patientes ayant eu un cancer dans l’enfance ou l’adolescence apparaît nécessaire pour limiter les risques d’altération de la fertilité. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cancer |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | fertilité |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | gamètes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | ovocytes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | préservation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | qualité |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | spermatozoïdes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | tissu ovarien |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cancer |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | fertility |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | gametes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | oocytes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | ovarian tissue |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | preservation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | quality |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | sperm |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chalas, Céline |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Médecine de la Reproduction | 26 | 1 | 2024-01-09 | p. 49-54 | 2650-8427 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://stm.cairn.info/revue-medecine-de-la-reproduction-2024-1-page-49?lang=fr&redirect-ssocas=7080">https://stm.cairn.info/revue-medecine-de-la-reproduction-2024-1-page-49?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux